OLI Version 12.7 simplifies chemistry data workflows with Excel data exchange

OLI released Version 12.7, adding Excel import/export for selected OLI Studio analyses to reduce manual data entry and support results reporting. The update also adds a Simple Membrane unit in OLI Flowsheet: ESP for modeling nanofiltration and other ion-selective separations, including water treatment and lithium recovery; it calculates permeate and concentrate streams while retaining thermodynamic and thermophysical calculations. Version 12.7 is available to download now.

Analysis

The strategic value is workflow friction reduction, not evidence of a new chemistry breakthrough. Excel interoperability could lower the trial barrier for OLI Studio and improve retention among teams whose data and reporting already live in spreadsheets. The second-order risk is that easier data movement cuts both ways: it may make OLI easier to evaluate, but also reduces workflow lock-in if customers compare competing simulation tools. Durable differentiation still depends on the underlying thermodynamic models and their validation, not the import/export layer.

The membrane unit is relevant to water treatment and lithium-recovery modeling, but user-specified ion rejection rates are not proof of predictive membrane performance or improved commercial recovery economics. Treat this as expanded addressable use-case coverage, not a near-term lithium-supply catalyst. No customer wins, paid upgrades, adoption metrics, or revenue contribution are disclosed; OLI’s public-market exposure is also not established by the supplied data.

Near term, expect limited market impact. Over 1–3 months, the useful signal is whether OLI reports customer uptake, paid conversions, or broader deployment beyond the initially supported objects. Over 6–18 months, validated use in operating projects could support retention and cross-selling, while weak adoption or competing tools offering equivalent workflows would leave the release as table stakes. The thesis is falsified by negligible uptake, no expansion in supported workflows, or evidence that membrane outputs require extensive customer-side calibration before they inform decisions.

Key Decisions for Investors

• No direct trade: the release does not establish a listed security, material financial impact, or customer adoption sufficient to underwrite an equity position.
• Track OLI for paid upgrade/conversion data, customer references, and expansion of Excel support beyond Stream Analyzer and ScaleChem; treat those as adoption alerts rather than assuming revenue from availability alone.
• For water-treatment and lithium-recovery exposures, do not revise production or supply assumptions on this modeling feature. Reassess only if operators validate the model against real process data and disclose deployment or economics.
• Watch competing process-simulation vendors for comparable spreadsheet workflows and membrane-model releases; an equivalent offering could neutralize OLI’s differentiation, while validated OLI customer outcomes could strengthen retention.